NIH-funded research NIH-funded research

Retinal signals in early diabetes and how they affect vision

Official title: Retinal neuronal signaling in early diabetes

Funded at University of Arizona · NIH-11641965 · Data updated 2026-11-12

This grant looks at how diabetes changes the signals in the retina that control vision, with a focus on inner retinal cells and how these changes may lead to vision problems.

More Diabetes research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Arizona
NIH-funded
Lab location1 site (Tucson, United States)
Project startDecember 1, 2015
Project endSeptember 29, 2028
Funding year2026
Award (this year)$1,005,703
NIH project number2R56EY026027-10
Project IDNIH-11641965 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with diabetes who are at risk for or beginning to experience diabetic retinopathy and are willing to participate in future translational investigations or related studies.

Less likely to help

Patients without diabetes or with advanced retinal disease not related to diabetes may have limited direct benefit.

What this research studies

In people with diabetes, early vision issues are linked to how retinal neurons communicate. The project studies inner retinal cells in a mouse model to understand how diabetes alters signaling and structure in bipolar, ganglion, and amacrine cells. It will examine calcium and dopamine pathways and how these changes relate to light-evoked vision loss. The researchers aim to identify potential targets to prevent or slow neuronal vision problems in diabetic retinopathy. The work builds on prior findings of altered cell responses and seeks to map differences among ganglion cell types to refine future interventions.

Why it matters

Potential benefit: If successful, this research could reveal new targets to protect retinal neurons and preserve vision in people with diabetes.

How similar studies have gone: Previous studies have shown diabetes can alter retinal signaling in mice, suggesting this approach could identify actionable mechanisms in humans.

Where this research is happening

  • University of Arizona
    Tucson, United States
    Active

Researchers

  • Principal investigator: Eggers, Erika D. — University of Arizona
  • Study coordinator: Eggers, Erika D.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.